- 2024.
- 2023.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
- 2024.
- 2023.
- 2022.
- 2021.
- 2020.
- 2019.
- 2018.
- 2017.
- 2016.
- 2015.
- 2014.
- 2013.
- 2012.
- 2011.
- 2010.
- 2009.
- 2008.
- 2007.
- 2006.
- 2005.
- 2004.
- 2003.
- 2002.
- 2001.
- 2000.
- 1999.
- 1998.
2023.
2021.
-
- May.19.2021 Products
- Ono and Seikagaku Announce the Launch of JOYCLU® 30mg Intra-articular Injection, a Joint Function Improvement Agent, in Japan
-
- Apr.21.2021 Products
- Launch of Adlumiz® (anamorelin), a Ghrelin Receptor Agonist in Japan
- Provides a New Treatment Option to Patients with Cancer Cachexia in Malignant Tumors -
-
- Feb.01.2021 Products
- ONO Announces Transfer of the Manufacturing and Marketing Approval Authorization for Kinedak Tablets to Alfresa Pharma Corporation
2020.
-
- Dec.21.2020 Products
- Launch of Parsabiv® Intravenous Injection Syringe for Dialysis, a Calcimimetic Agent in Japan(168 KB)
-
- Aug.26.2020 Products
- Launch of Ongentys® Tablets 25mg, a Peripheral COMT Inhibitor in Japan(173 KB)
-
- May.20.2020 Products
- Launch of Velexbru® Tablet 80mg, a Bruton’s Tyrosine Kinase Inhibitor in Japan(216 KB)
2019.
-
- Nov.19.2019 Products
- Launch of Coralan® Tablet, an HCN Channel Blocker in Japan(239 KB)
-
- Feb.26.2019 Products
- Launch of BRAFTOVI® Capsule 50 mg, a BRAF Inhibitor and MEKTOVI® Tablet 15 mg, a MEK Inhibitor in Japan(171 KB)
-
- Feb.26.2019 Products
- Launch of Demser® Capsule 250 mg, a Tyrosine Hydroxylase Inhibitor in Japan(82 KB)